In 2023, Business Enterprise R&D Expenditure in Human Health Activities in Germany was estimated to stand below the projected figures for 2024-2028. Observing the forecast data, from 2024 ($13.47M) to 2028 ($21.5M), a consistent growth trend is apparent, marking a Compound Annual Growth Rate (CAGR) over these five years. Year-on-year growth is expected with varying percentages: approximately 15% from 2024 to 2025, continuing upwards at slightly diminishing rates up to 2028.
Future trends to watch for include increased technology integration in R&D, healthcare digitization, and sustainable healthcare solutions potentially influencing expenditure trends. Monitoring regulatory impacts and international collaborations may also be crucial factors.
